Last updated: July 10, 2025
Sponsor: Kasr El Aini Hospital
Overall Status: Active - Recruiting
Phase
N/A
Condition
N/ATreatment
ketamine-dexmedetomidine admixture induction of Anesthesia
Clinical Study ID
NCT07002073
MD-451-2024
Ages > 65 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Participants will be elderly patients (>65 years), ASA I-III, scheduled for electivenon-cardiac surgery under general anesthesia.
Exclusion
Exclusion Criteria:
- Patients with severe cardiac morbidities (impaired contractility with ejectionfraction < 50%, heart block, arrhythmias, tight valvular lesions, metabolicequivalent [MET] less than 4, patients on angiotensin converting enzyme inhibitorsand angiotensin receptor blockers medications, patients with uncontrolledhypertension, patients undergoing adrenalectomy, patients with body mass index <18or > 35 Kg/m2), patient with allergy of any of the study drugs will be excluded fromthe study and if the patient is considered to be difficult intubation inpreoperative assessment will be excluded as well.
Study Design
Total Participants: 102
Treatment Group(s): 1
Primary Treatment: ketamine-dexmedetomidine admixture induction of Anesthesia
Phase:
Study Start date:
January 01, 2025
Estimated Completion Date:
February 15, 2026
Study Description
Connect with a study center
Cairo University Hospitals
Cairo, Giza
EgyptActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.